| Literature DB >> 32545878 |
Hee-Sook Lim1, Yong Jin Kim2, Jihyun Lee3, Su-Jin Yoon4, Bora Lee5.
Abstract
Although bariatric surgery is the best treatment modality for morbidly obese patients, a 10-30% rate of weight recidivism has been reported in various specialized centers. We examined changes in energy and macronutrients after bariatric surgery and performed analysis to establish appropriate nutritional guidelines for reaching the target percentage of weight loss after surgery. A total of 189 subjects who underwent bariatric surgery were classified into success and failure groups depending on whether or not they reached 50% loss of excess weight at 12 months after bariatric surgery. Physical examinations and dietary surveys were completed before and 1, 6, and 12 months after surgery. Using receiver operating characteristic (ROC) analysis, the optimal cutoff points for nutrient intakes for determining success after bariatric surgery were computed based on maximal Youden's index. At 6 and 12 months after surgery, the success group had significantly lower carbohydrate and fat intakes than the failure group. The cutoff calorie intake for success in weight loss was <835.0, <1132.5, and <1523.0 kcal/day at 1, 6, and 12 months post operation, respectively. With regard to protein, the cutoff intakes were >44.5, >41.5, and >86.5 g/day at 1, 6, and 12 months post operation, respectively. At 12 months, the cutoff ratio for energy obtained from carbohydrates, protein, and fat was <49.0, >24.5, and <28.0%, respectively. Our findings confirm that the level of diet control and nutrition restriction affect the achievement of target weight loss, emphasizing that long-term weight loss is related to compliance with nutrient recommendations.Entities:
Keywords: bariatric surgery; caloric restriction; diet; nutrition; weight loss
Year: 2020 PMID: 32545878 PMCID: PMC7353322 DOI: 10.3390/nu12061774
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Baseline characteristics in all patients.
| Variable | Total ( |
|---|---|
| Age (years) | 34.6 ± 10.7 |
| Sex | |
| Male | 54 (28.6%) |
| Female | 135 (71.4%) |
| Operative method | |
| LRYGB | 146 (77.2%) |
| SG | 43 (22.8%) |
| Comorbidity | |
| Yes | 43 (22.8%) |
| Diabetes | 18 (9.5%) |
| Hypertension | 10 (5.3%) |
| Hyperlipidemia | 11 (5.8%) |
| Joint problem | 6 (3.2%) |
| Depression | 4 (2.1%) |
| Apnea | 7 (3.7%) |
| Number of comorbidities | |
| One | 26 (60.4%) |
| Two | 11 (25.6%) |
| Three or more | 6 (14.0%) |
| Lifestyle habit | |
| Alcohol drinking | 66 (34.9%) |
| Smoking | 36 (19.0%) |
| Exercise | 28 (14.8%) |
| Experience of diet control | 86 (46.0%) |
| Weight (kg) | 108.0 ± 19.8 |
| BMI (kg/m2) | 38.9 ± 5.9 |
| Excess weight (kg) | 44.2 ± 16.6 |
| Fat Mass (kg) | 55.7 ± 11.3 |
| Fat Free Mass (kg) | 51.6 ± 13.9 |
LRYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy. Data are reported as mean ± SD for continuous variables and n (%) for categorical variables.
Changes in percentage of excess weight loss (%EWL) between two groups.
| Variable | Total | Achievement of Weight Loss | Operative Method | Comorbidity | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Success | Failure | LRYGB | SG | Yes | No | |||||
| Postop 1 month | 24.69 ± 9.23 | 25.85 ± 10.00 | 22.50 ± 6.52 | 0.005 | 24.52 ± 9.66 | 25.24 ± 7.64 | 0.615 | 24.59 ± 7.82 | 25.25 ± 13.39 | 0.695 |
| Postop 3 months | 41.66 ± 11.57 | 45.38 ± 10.87 | 34.03 ± 8.96 | <0.001 | 42.18 ± 12.91 | 41.50 ± 11.19 | 0.736 | 45.35 ± 16.06 | 48.71 ± 17.57 | 0.258 |
| Postop 6 months | 46.42 ± 17.27 | 52.76 ± 17.12 | 33.48 ± 7.78 | <0.001 | 50.05 ± 18.66 | 46.67 ± 16.75 | 0.289 | 41.98 ± 10.87 | 42.24 ± 13.58 | 0.900 |
| Postop 12 months | 53.05 ± 15.90 | 61.71 ± 7.90 | 37.46 ± 10.21 | <0.001 | 54.40 ± 16.38 | 53.57 ± 13.75 | 0.762 | 53.15 ± 14.80 | 54.81 ± 13.81 | 0.511 |
LRYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy. Data are reported as mean ± SD and p-values were calculated with Wilcoxon’s rank-sum test.
Comparison of nutrition intakes between two groups.
| Variable | Calorie (kcal) | Carbohydrate (g) | Protein (g) | Fat (g) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Success | Failure | Success | Failure | Success | Failure | Success | Failure | |||||
| Preop | 2282.97 ± 626.93 | 2234.31 ± 609.10 | 0.610 | 293.31 ± 90.00 (53.5%) | 311.18 ± 113.16 (56.4%) | 0.280 | 92.06 ± 32.42 (16.8%) | 84.02 ± 28.75 (15.1%) | 0.086 | 74.24 ± 32.67 (29.9%) | 70.77 ± 31.61 (28.5%) | 0.485 |
| Postop 1 month | 769.33 ± 217.88 | 765.73 ± 178.30 | 0.904 | 70.48 ± 34.82 (36.7%) | 70.56 ± 35.47 (39.6%) a | 0.987 | 58.02 ± 21.95 (30.1%) | 50.55 ± 23.74 (28.9%) | 0.040 | 30.04 ± 14.53 (33.2%) | 27.59 ± 14.25 (31.5%) | 0.272 |
| Postop 6 months | 999.82 ± 259.30 | 1120.81 ± 272.43 | 0.004 | 97.58 ± 44.1 (40.6%) | 133.98 ± 54.96 (46.4%) | <0.001 | 57.87 ± 20.91 (25.4%) | 53.79 ± 18.06 (20.2%) b | 0.169 | 34.71 ± 11.53 (34.0%) | 38.98 ± 12.10 (33.4%) | 0.022 |
| Postop 12 months | 1336.75 ± 229.03 | 1646.21 ± 315.55 | <0.001 | 139.13 ± 49.04 (48.4%) | 198.60 ± 81.10 (53.1%) A | <0.001 | 79.19 ± 24.09 (28.0%) | 70.43 ± 25.04 (20.4%) B | 0.023 | 47.87 ± 12.32 (23.6%) | 59.42 ± 17.53 (26.5%) C | <0.001 |
Data are reported as mean ± SD. P-values were computed by Wilcoxon’s rank-sum test. Numbers of patients were 127 for success and 62 for failure. Data in parentheses report the average energy ratio for each macronutrient intake. (a p < 0.05 vs. carbohydrate in postop 1 month, A p < 0.01 vs. carbohydrate in postop 12 months, b p < 0.05 vs. protein in postop 6 months, B p < 0.05 vs. protein in postop 12 months, C p < 0.05 vs. fat in postop 12 months).
Figure 1Scatterplot representing the association between %EWL and macronutrient composition at postop 12 months. (a) correlation between %EWL and calorie, (b) correlation between %EWL and carbohydrate, (c) correlation between %EWL and fat, (d) correlation between %EWL and fat. Group 1; Success, Group 2; Failure. P-value was computed by pearson correlation test.
Logistic regression analysis for the success in patients.
| Variable | Univariable | Multiple 1 | Multiple 2 | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Age (year) | 0.96 (0.93–0.99) | 0.009 | 0.97 (0.94–0.99) | 0.046 | 0.96 (0.93–0.99) | 0.027 |
| Female | 1.83 (0.94–3.52) | 0.072 | ||||
| LRYGB | 0.74 (0.34–1.54) | 0.437 | ||||
| No. of comorbidities | 0.85 (0.65–1.13) | 0.249 | ||||
| Calorie (100 kcal) | ||||||
| at 1 month | 1.05 (0.91–1.22) | 0.515 | ||||
| at 6 months | 0.78 (0.68–0.88) | <0.001 | ||||
| at 12 months | 0.37 (0.27–0.48) | <0.001 | ||||
| Carbohydrates (10 g) | ||||||
| at 1 month | 0.98 (0.9–1.07) | 0.607 | ||||
| at 6 months | 0.85 (0.78–0.91) | <0.001 | ||||
| at 12 months | 0.63 (0.54–0.72) | <0.001 | ||||
| Protein (10 g) | ||||||
| at 1 month | 1.17 (1.01–1.36) | 0.038 | ||||
| at 6 months | 0.99 (0.85–1.15) | 0.853 | ||||
| at 12 months | 0.85 (0.74–0.96) | 0.008 | ||||
| Fat (10 g) | ||||||
| at 1 month | 1.11 (0.9–1.39) | 0.323 | ||||
| at 6 months | 0.55 (0.41–0.72) | <0.001 | ||||
| at 12 months | 0.46 (0.35–0.6) | <0.001 | ||||
| Proportion of calories at 12 months | ||||||
| Carbohydrate (%) | 0.98 (0.98–0.99) | <0.001 | 0.98 (0.98–0.99) | <0.001 | 0.99 (0.98–0.99) | <0.001 |
| Protein (%) | 0.99 (0.97–1.00) | 0.026 | 0.99 (0.97–1.00) | 0.171 | ||
| Fat (%) | 0.95 (0.93–0.97) | <0.001 | 0.96 (0.93–0.99) | 0.002 | 0.96 (0.93–0.98) | <0.001 |
OR, odds ratio; CI, confidence interval.
Prognostic performance for the success in patients.
| Variable | AUC (95% CI) | Optimal Cutoff * | Estimates (95% CI) | ||||
|---|---|---|---|---|---|---|---|
| Sensitivity | Specificity | Accuracy | LR (+) | LR (−) | |||
| Calories (kcal) | |||||||
| at 1 month | 0.529 (0.442–0.615) | <835.0 | 0.57 (0.48–0.65) | 0.32 (0.21–0.45) | 0.49 (0.41–0.56) | 0.84 (0.67–1.05) | 1.34 (0.89–2.03) |
| at 6 months | 0.673 (0.593–0.754) | <1132.5 | 0.75 (0.66–0.82) | 0.55 (0.42–0.68) | 0.68 (0.61–0.75) | 1.66 (1.24–2.22) | 0.46 (0.32–0.67) |
| at 12 months | 0.912 (0.872–0.953) | <1523.0 | 0.87 (0.79–0.92) | 0.82 (0.7–0.91) | 0.85 (0.79–0.90) | 4.88 (2.84–8.38) | 0.16 (0.10–0.26) |
| Carbohydrate (g) | |||||||
| at 1 month | 0.513 (0.424–0.602) | <115.5 | 0.91 (0.85–0.96) | 0.15 (0.07–0.26) | 0.66 (0.59–0.73) | 1.07 (0.95–1.20) | 0.60 (0.26–1.36) |
| at 6 months | 0.703 (0.624–0.781) | <103.0 | 0.58 (0.49–0.67) | 0.79 (0.67–0.88) | 0.65 (0.58–0.72) | 2.78 (1.68–4.61) | 0.53 (0.41–0.67) |
| at 12 months | 0.878 (0.819–0.937) | <172.5 | 0.93 (0.87–0.97) | 0.76 (0.63–0.86) | 0.87 (0.82–0.92) | 3.84 (2.47–5.98) | 0.09 (0.05–0.18) |
| Protein (g) | |||||||
| at 1 month | 0.617 (0.529–0.705) | >44.5 | 0.76 (0.67–0.83) | 0.52 (0.39–0.65) | 0.68 (0.61–0.74) | 1.56 (1.19–2.06) | 0.47 (0.32–0.70) |
| at 6 months | 0.524 (0.440–0.609) | >41.5 | 0.86 (0.79–0.91) | 0.02 (0.00–0.09) | 0.58 (0.51–0.65) | 0.87 (0.81–0.94) | 8.79 (1.02–64.33) |
| at 12 months | 0.618 (0.531–0.705) | >86.5 | 0.21 (0.15–0.29) | 0.55 (0.42–0.68) | 0.32 (0.26–0.39) | 0.47 (0.31–0.73) | 1.44 (1.13–1.83) |
| Fat (g) | |||||||
| at 1 month | 0.564 (0.475–0.652) | <21.5 | 0.49 (0.38–0.61) | 0.58 (0.48–0.67) | 0.54 (0.47–0.62) | 0.58 (0.4–0.83) | 1.45 (1.09–1.92) |
| at 6 months | 0.682 (0.599–0.766) | <46.5 | 0.85 (0.78–0.91) | 0.48 (0.35–0.61) | 0.73 (0.66–0.79) | 1.65 (1.28–2.12) | 0.31 (0.19–0.50) |
| at 12 months | 0.781 (0.709–0.853) | <52.5 | 0.78 (0.70–0.85) | 0.69 (0.56–0.8) | 0.75 (0.68–0.81) | 2.54 (1.73–3.74) | 0.32 (0.22–0.46) |
| Proportion of calorie at 12 months | |||||||
| Carbohydrate (%) | 0.714 (0.637–0.792) | <49.0 | 0.85 (0.78–0.91) | 0.60 (0.46–0.72) | 0.77 (0.7–0.83) | 2.11 (1.54–2.88) | 0.25 (0.16–0.40) |
| Protein (%) | 0.609 (0.523–0.695) | >24.5 | 0.52 (0.40–0.64) | 0.74 (0.65–0.81) | 0.65 (0.58–0.72) | 1.98 (1.36–2.88) | 0.65 (0.50–0.84) |
| Fat (%) | 0.855 (0.792–0.917) | <28.0 | 0.73 (0.65–0.81) | 0.60 (0.46–0.72) | 0.69 (0.62–0.75) | 1.82 (1.32–2.50) | 0.45 (0.32–0.64) |
CI, confidence interval; AUC, area under the curve; LR, likelihood ratio. * based on Youden’s index.